Connecticut et al v. Teva Pharmaceuticals USA, Inc.
Case Number:
3:19-cv-00710
Court:
Nature of Suit:
Judge:
Firms
- Arnold & Porter
- Baker Botts
- Ballard Spahr
- Barnes & Thornburg
- Buchanan Ingersoll
- Clifford Chance
- Competition Law Partners
- Cozen O'Connor
- Curtis Mallet-Prevost
- Day Pitney
- Debevoise & Plimpton
- Dechert LLP
- DeCotiis FitzPatrick
- DLA Piper
- Foley & Lardner
- Gage Spencer & Fleming
- Greenberg Traurig
- Hogan Lovells
- Izard Kindall
- Kasowitz Benson
- Kelley Drye
- Kirkland & Ellis
- Krantz & Berman
- Morgan Lewis
- Morrison Foerster
- O'Toole & O'Toole
- Proskauer Rose
- Reed Smith
- Saxton & Stump
- Schertler Onorato
- Seward & Kissel
- Shapiro Arato
- Skadden Arps
- Troutman
- Welsh & Recker
- Wiggin & Dana
- Williams & Connolly
- WilmerHale
- Wilson Sonsini
Companies
- Allergan PLC
- Amneal Pharmaceuticals Inc.
- Aurobindo Pharma Ltd.
- Breckenridge Pharmaceutical Inc.
- Dr. Reddy's Laboratories Ltd.
- Glenmark Pharmaceuticals Ltd.
- Lannett Company, Inc
- Lupin Ltd.
- Novartis AG
- Pfizer Inc.
- Sandoz International GmbH
- Teva Pharmaceutical Industries Ltd.
- Upsher-Smith Laboratories Inc.
- Viatris Inc.
- Wockhardt USA LLC
- Zydus Pharmaceuticals Inc.
Government Agencies
- Commonwealth of Kentucky
- Commonwealth of Massachusetts
- State of Indiana
- State of Maryland
- State of Michigan
- State of Nevada
- State of Tennessee
- U.S. District Court for the District of Columbia
Sectors & Industries:
-
August 15, 2024
Price-Fixing Claims Against Par Pharma Tossed After Ch. 11
A Connecticut federal judge on Thursday tossed Par Pharmaceutical Cos. Inc. from two price-fixing lawsuits after the defendant and its parent, Endo International PLC, recently filed the Chapter 11 reorganization plans that they said shielded them from the cases.
-
July 22, 2024
Price-Fixing Claims Against Par Pharma On Chopping Block
A Connecticut federal judge has asked a coalition of states to explain why he shouldn't toss two price-fixing lawsuits against Par Pharmaceutical Companies Inc., noting that the defendant and its parent, Endo International PLC, recently filed Chapter 11 reorganization plans shielding them from the cases.
-
July 01, 2024
State AGs Get Stay Lifted In Generic Drug Pricing Litigation
A Connecticut federal judge on Monday agreed to lift a partial discovery stay in a trio of generic drug pricing antitrust suits led by the attorneys general of New York and Connecticut, according to a short, text-only order posted to each of the case dockets.
-
June 27, 2024
State AGs Want Stay Lifted In Generic Drug Pricing Suit
The attorneys general of New York and Connecticut have asked a federal judge to lift a partial discovery stay in three state-led generic drug pricing lawsuits against the pharmaceutical industry, saying it is no longer necessary because sentencing is complete in a parallel U.S. Department of Justice proceeding.
-
June 03, 2024
Drug Cos. Can Depose DC AG In Drug Price-Fixing Row
A Connecticut federal judge reluctantly ordered the District of Columbia Attorney General's Office to be deposed by the drug companies wrapped up in more than 40 states' claims over an alleged price-fixing conspiracy, noting that he would not have done so but for the case being remanded from a sprawling multidistrict litigation in Pennsylvania.
-
April 25, 2024
Conn. Judge In Drug Price-Fixing Suit Reveals Day Pitney Ties
U.S. District Judge Michael P. Shea of the District of Connecticut said Thursday he will not recuse himself from overseeing state enforcers' price-fixing claims against Sandoz Inc. and other drug companies despite Sandoz's attorneys being from Day Pitney LLP, where he was once a partner.
-
February 01, 2024
State-Led Generic Drug Cases Removed From MDL
The Judicial Panel on Multidistrict Litigation has sent a trio of cases from state-level enforcers back to federal court in Connecticut, separating them from the sprawling MDL centralized in Pennsylvania over claims of price fixing in the generic drug industry.
-
June 24, 2019
Drugmakers' Emails, Calls Show Price-Fix Coverup, AGs Say
Unredacted emails and phone records show Teva Pharmaceuticals, Pfizer Inc. and 18 other major U.S. drug manufacturers conspiring in an industrywide price-fixing scheme to keep the cost of hundreds of generic drugs artificially high, according to a complaint unsealed Monday by the Maryland attorney general's office.
-
June 04, 2019
44 States' Generic-Drug Pricing Suit Rolled Into Pa. MDL
A lawsuit filed in Connecticut last month by 44 state attorneys general accusing drugmakers of a sprawling scheme to fix generic-drug prices was transferred Tuesday to the Pennsylvania federal court overseeing multidistrict litigation over pricing in the industry.
-
May 13, 2019
Teva A 'Consistent Participant' In Drug Price-Fixing, AGs Say
Teva Pharmaceuticals is at the center of a sprawling new lawsuit in Connecticut in which a coalition of 44 state attorneys general accuse the drugmaker and more than a dozen rivals of conspiring to keep generics prices artificially high.
- ← Previous
- 1
- 2
- Next →